Lic Mf Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 19-10-2026
NAV ₹31.39(R) -1.08% ₹34.83(D) -1.07%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 4.01% 18.22% -% -% -%
Direct 5.39% 19.72% -% -% -%
Benchmark
SIP (XIRR) Regular 6.96% 9.64% -% -% -%
Direct -% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 86 Cr
Top Pharma Fund
Fund Name Rank Rating
SBI Healthcare Opportunities Fund -
UTI Healthcare Fund -
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
DSP Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -
Mirae Asset Healthcare Fund -
Nippon India Pharma Fund -
Tata India Pharma & Healthcare Fund -

NAV Date: 19-10-2026

Scheme Name NAV Rupee Change Percent Change
LIC MF Healthcare Fund-Regular Plan-Growth 31.39
-0.3400
-1.0800%
LIC MF Healthcare Fund-Regular Plan-IDCW 31.39
-0.3400
-1.0800%
LIC MF Healthcare Fund-Direct Plan-IDCW 34.82
-0.3800
-1.0700%
LIC MF Healthcare Fund-Direct Plan-Growth 34.83
-0.3800
-1.0700%

Review Date: 19-10-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -8.83 -5.20
-7.97
-8.83 | -6.35 17 | 17 Poor
3M Return % -4.46 -1.40
-4.40
-7.14 | -1.39 9 | 17 Good
6M Return % 10.53 14.47
10.92
5.22 | 17.28 11 | 17 Average
1Y Return % 4.01 14.83
7.87
-0.52 | 16.24 12 | 16 Average
3Y Return % 18.22 19.60
18.52
14.89 | 26.33 6 | 11 Good
1Y SIP Return % 6.96
7.11
-19.70 | 20.51 9 | 16 Average
3Y SIP Return % 9.64
9.46
-1.46 | 18.93 5 | 11 Good
Return data last Updated On : Oct. 19, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -8.73 -5.20 -7.88 -8.73 | -6.29 17 | 17 Poor
3M Return % -4.15 -1.40 -4.09 -6.82 | -0.99 9 | 17 Good
6M Return % 11.25 14.47 11.66 5.95 | 18.20 11 | 17 Average
1Y Return % 5.39 14.83 9.33 0.89 | 17.55 12 | 16 Average
3Y Return % 19.72 19.60 19.97 15.92 | 27.83 6 | 11 Good
Return data last Updated On : Oct. 19, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Lic Mf Healthcare Fund NAV Regular Growth Lic Mf Healthcare Fund NAV Direct Growth
19-10-2026 31.3889 34.8271
16-10-2026 31.7306 35.2025
15-10-2026 31.928 35.4202
14-10-2026 31.8553 35.3383
13-10-2026 32.1768 35.6936
12-10-2026 32.2806 35.8076
09-10-2026 32.3131 35.8397
08-10-2026 32.0646 35.5629
07-10-2026 32.8253 36.4053
06-10-2026 32.9172 36.5059
05-10-2026 32.6253 36.1809
01-10-2026 32.8383 36.4119
30-09-2026 32.898 36.4768
29-09-2026 33.7967 37.4719
28-09-2026 33.8667 37.5481
25-09-2026 34.293 38.0167
24-09-2026 34.3049 38.0286
23-09-2026 34.5081 38.2525
22-09-2026 34.245 37.9595
21-09-2026 34.4272 38.1601

Fund Launch Date: 28/Feb/2019
Fund Category: Pharma Fund
Investment Objective: The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Description: An open-ended equity scheme investing in Healthcare and Allied sectors
Fund Benchmark: BSE Healthcare- TRI
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.